Retatrutide, from Soma Chems , represents a promising breakthrough in metabolic control . This dual-action compound combines GLP-1 receptor agonist function with gut-derived receptor agonist activation , indicating impressive efficacy in trial studies for body reduction . Experts believe this treatment is expected to represent a new pathway for ind